SURETRAK
Device
Medtronic, Inc.
Total Payments
$1.7M
Transactions
30
Doctors
5
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $442,827 | 4 | 1 |
| 2022 | $588,166 | 4 | 1 |
| 2021 | $466,414 | 7 | 4 |
| 2020 | $5,030 | 3 | 1 |
| 2019 | $28,967 | 4 | 1 |
| 2018 | $49,249 | 5 | 2 |
| 2017 | $74,012 | 3 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.7M | 26 | 100.0% |
| Travel and Lodging | $226.00 | 1 | 0.0% |
| Food and Beverage | $97.82 | 3 | 0.0% |
Top Doctors Receiving Payments for SURETRAK
Ad
Manufacturing Companies
- Medtronic, Inc. $1.5M
- Medtronic USA, Inc. $157,258
Product Information
- Type Device
- Total Payments $1.7M
- Total Doctors 5
- Transactions 30
About SURETRAK
SURETRAK is a device associated with $1.7M in payments to 5 healthcare providers, recorded across 30 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic, Inc..
Payment data is available from 2017 to 2023. In 2023, $442,827 was paid across 4 transactions to 1 doctors.
The most common payment nature for SURETRAK is "Royalty or License" ($1.7M, 100.0% of total).